▁the ▁campaign , ▁would ▁like ▁to ▁address ▁the ▁system atic ▁fla ws ▁in ▁clin ical ▁research ▁which ▁cause ▁data ▁to ▁be ▁lost ▁after ▁it ▁is ▁gathered . ▁ ▁Cover age ▁ ▁The ▁campaign ▁has ▁been ▁widely ▁covered , ▁and ▁supported , ▁in ▁the ▁academic ▁press . ▁The ▁British ▁Medical ▁Journal ▁and ▁PL OS ▁are ▁found ing ▁members . ▁Nature ▁and ▁The ▁Lanc et ▁both ▁published ▁support ive ▁articles ▁in ▁January ▁ 2 0 1 4 . ▁ ▁There ▁has ▁also ▁been ▁main stream ▁media ▁coverage . ▁ ▁Cont ro vers y ▁ ▁There ▁has ▁been ▁criticism ▁from ▁the ▁Ph arma ce ut ical ▁Research ▁and ▁Man ufact ur ers ▁of ▁America ▁( Ph R MA ), ▁with ▁senior ▁vice - pres ident ▁Matt ▁Ben nett ▁saying ▁that ▁trial ▁data ▁dis closure ▁measures ▁which ▁All Tri als ▁has ▁recommended ▁to ▁the ▁European ▁Medic ines ▁Agency ▁ ▁" could ▁risk ▁patient ▁priv acy , ▁lead ▁to ▁fewer ▁clin ical ▁tri als , ▁and ▁result ▁in ▁fewer ▁new ▁medic ines ▁to ▁meet ▁patient ▁needs ▁and ▁improve ▁health ." . ▁ ▁All Tri als ▁have ▁published ▁a ▁detailed ▁statement ▁of ▁exactly ▁what ▁they ▁want ▁to ▁see ▁published , ▁which ▁states ▁" The ▁All Tri als ▁campaign ▁is ▁not ▁calling ▁for ▁individual ▁patient ▁data ▁to ▁be ▁made ▁public ly ▁available ". ▁ ▁A ▁ 2 0 1 2 ▁editor ial ▁published ▁by ▁senior ▁regul ators ▁from ▁the ▁European ▁Medic ines ▁ag ency ▁largely ▁agreed ▁with ▁All Tri als , ▁saying ▁" We ▁consider ▁it ▁neither ▁des irable ▁nor